- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Ludwig Institute for Cancer Research
Total 10615 results
-
Ludwig Institute for Cancer ResearchCompleted
-
Ludwig Institute for Cancer ResearchTerminated
-
Ludwig Institute for Cancer ResearchCompletedCancer | NeoplasmGermany
-
Ludwig Institute for Cancer ResearchTerminated
-
Ludwig Institute for Cancer ResearchCompleted
-
Ludwig Institute for Cancer ResearchCompletedProstate CancerSwitzerland, Germany
-
Ludwig Institute for Cancer ResearchCompletedColorectal CancerSwitzerland, Germany
-
Ludwig Institute for Cancer ResearchTerminatedColorectal CancerUnited States
-
Ludwig Institute for Cancer ResearchAstraZenecaCompletedEsophageal CancerUnited Kingdom
-
Ludwig Institute for Cancer ResearchMedarexTerminatedSynovial SarcomaUnited States
-
Ludwig Institute for Cancer ResearchAgonOxWithdrawn
-
Ludwig Institute for Cancer ResearchCancer Research Institute (CRI)CompletedMalignant MelanomaUnited States
-
Ludwig Institute for Cancer ResearchKrankenhaus NordwestCompletedMelanoma | Sarcoma | Breast Cancer | Head and Neck Cancer | Esophageal Cancer | Transitional Cell Carcinoma | Prostate Cancer | Ovarian Carcinoma | Gastrointestinal Stromal Tumor (GIST)Germany
-
Ludwig Institute for Cancer ResearchMie UniversityCompletedStomach Cancer | Breast Cancer | Esophageal Cancer | Ovarian Cancer | Lung CancerJapan
-
Ludwig Institute for Cancer ResearchCancer Research Institute, NY, USATerminatedNY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic MelanomaUnresectable or Metastatic MelanomaUnited States, Australia
-
Ludwig Institute for Cancer ResearchNational Cancer Institute (NCI)TerminatedOvarian CancerUnited States
-
Ludwig Institute for Cancer ResearchNational Cancer Institute (NCI)CompletedColorectal NeoplasmsAustralia
-
Ludwig Institute for Cancer ResearchNational Cancer Institute (NCI)CompletedOvarian CancerUnited States
-
Ludwig Institute for Cancer ResearchNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
Ludwig Institute for Cancer ResearchRoswell Park Cancer InstituteCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerUnited States
-
Ludwig Institute for Cancer ResearchNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
Ludwig Institute for Cancer ResearchNational Cancer Institute (NCI)CompletedKidney CancerUnited States
-
Ludwig Institute for Cancer ResearchNational Cancer Institute (NCI)CompletedTransitional Cell CarcinomaUnited States
-
Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer CenterCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUnited States
-
Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer CenterCompletedKidney Cancer | Renal Cell Carcinoma | Renal Cancer | Kidney NeoplasmUnited States
-
Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer CenterCompletedKidney Cancer | Clear Cell Renal Cell Carcinoma | Renal Cancer | Renal Cell Carcinoma (RCC) | Renal Neoplasms | Cancer of Kidney | Neoplasms, KidneyUnited States
-
Ludwig Institute for Cancer ResearchRadboud University Medical CenterCompletedMetastatic Renal Cell CarcinomaNetherlands
-
Memorial Sloan Kettering Cancer CenterLudwig Institute for Cancer ResearchActive, not recruitingColorectal Neoplasms | Colorectal Cancer | Colorectal Tumor | COlorectal CarcinomaUnited States
-
Ludwig Institute for Cancer ResearchInstitute of Cancer Research, United KingdomCompletedMelanomaUnited Kingdom, Australia, New Zealand
-
Ludwig Institute for Cancer ResearchDaiichi Sankyo, Inc.CompletedA Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal CancerColorectal NeoplasmsAustralia
-
Ludwig Institute for Cancer ResearchNYU Langone HealthCompletedTumorsUnited States
-
Ludwig Institute for Cancer ResearchBristol-Myers SquibbTerminatedMetastatic MelanomaAustralia
-
NYU Langone HealthLudwig Institute for Cancer ResearchTerminatedCutaneous T-cell LymphomaUnited States
-
Ludwig Institute for Cancer ResearchJohns Hopkins UniversityWithdrawnSolid Tumors | LymphomasGermany
-
Ludwig Institute for Cancer ResearchAustin Health; Peter MacCallum Cancer InstituteCompleted
-
Ludwig Institute for Cancer ResearchPfizer; Heidelberg Pharma AGTerminatedRenal Cell Carcinoma (RCC)Australia
-
Centre Hospitalier Universitaire VaudoisLudwig Institute for Cancer ResearchCompleted
-
Centre Hospitalier Universitaire VaudoisLudwig Institute for Cancer ResearchCompleted
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLCCompletedRenal Cell Carcinoma | Cervical Cancer | Breast Cancer | Colorectal Cancer | Ovarian CancerUnited States
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLCCompletedMelanoma | Sarcoma | Breast Cancer | Solid Tumor | Prostate Cancer | Bladder Cancer | Head and Neck Squamous Cell Carcinoma | Cutaneous T-Cell Lymphoma | Renal Cancer | Merkel Cell Carcinoma | Testicular CancerUnited States
-
Ludwig Institute for Cancer ResearchRoswell Park Cancer Institute; New York University Cancer InstituteCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerUnited States
-
Ludwig Institute for Cancer ResearchCelgene; Cancer Research Institute, New York City; MedImmune LLCCompletedOvarian CancerUnited States, Switzerland
-
Ludwig Institute for Cancer ResearchBristol-Myers Squibb; Conquer Cancer FoundationCompleted
-
Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center; NYU Langone HealthCompletedSkin Cancer | Metastatic Melanoma | NeoplasmUnited States
-
Memorial Sloan Kettering Cancer CenterOtsuka America Pharmaceutical; Ludwig Institute for Cancer ResearchCompleted
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLC; Targovax ASACompletedColorectal Cancer | Ovarian Cancer | Appendiceal CancerUnited States
-
Ludwig Institute for Cancer ResearchDaiichi Sankyo Co., Ltd.; Austin HealthCompletedMalignant Solid Tumor | Metastatic EphA2 Positive CancerAustralia
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLC; Multiple Myeloma Research...TerminatedPhase 1 Study of Tremelimumab, Durvalumab, High-dose Chemotherapy, + Autologous Stem Cell TransplantMultiple MyelomaUnited States
-
Ludwig Institute for Cancer ResearchBoehringer Ingelheim; MedImmune LLC; PharmaJet, Inc.; CureVac; Cancer Research Institute...CompletedNSCLC | Metastatic Non-small Cell Lung CancerUnited States
-
Ludwig Boltzmann Institute for Lung HealthCompletedVirus Diseases | COVID-19Austria